A SPECIAL
ANNOUNCEMENT FROM:
  Pharmaceutical Executive  
Artificial Intelligence Applied to Benefits Verification: Faster Access, Better Patient Experience
AI-powered eBV represents a potent mix of human and machine that could positively impact every stakeholder in the pharma continuum. Manufacturers who make the most of that balance with optimal tech choices will have the competitive advantage.

Download our new white paper, Beyond the Promise of Artificial Intelligence in Electronic Benefit Verification. 

You'll gain:
  • Insights into the differences between logic-based and AI-based approaches for benefit verification
  • Leading-edge innovations and technologies that push what's possible for eBV
  • How to evaluate and scale potential solutions for your unique needs

Take the first step in optimizing your solutions mix with this complimentary resource.
DOWNLOAD WHITE PAPER
 
How to Evaluate an eBV Product
Myra Reinhardt, Vice President of Product Innovation and Analytics at Lash Group, shares insights on how to choose an eBV solution. 
READ GUIDE
 
Connect With Lash Group
Looking for more information on solutions that help speed access to therapy for patients? Speak with one of our team members to learn more about our solutions. 
CONTACT LASH GROUP
 

Message above is a paid advertisement. Content is provided by the sponsor. You received this email because you are a customer of Pharmaceutical Executive, a MJH Life Sciences™ brand. You are on the mailing list as %%emailaddress%%.